- Summary
- STADA Spain has maintained double-digit growth, achieving record annual profits of 1 billion euros in 2023, driven mainly by Consumer Healthcare and Specialty STADA Health Report 2023. The pharmaceutical brand consolidated its positions in the market for venous diseases, diabetes and neurodegenerative diseases such as Parkinson's and osteoporosis, highlighting its role in risk prevention and screening. Additionally, STADA is recognized as one of the best pharmaceutical companies to lead Consumer Healthcare and generic drug markets, while also addressing environmental issues, such as reducing the logistics carbon footprint in the LeanGreen program. In the mental health space, STADA has supported campaigns to include people with Parkinson's disease and perimenopausal women, as well as leading global efforts such as International Osteoporosis and Alzheimer's Day.
- Title
- STADA | STADA
- Description
- STADA: Taking care of people's health as a trusted ally
- Keywords
- para, health, consumer, report, europa, personas, leer, care, healthcare, primer, employer
- NS Lookup
- A 104.21.48.125, A 172.67.151.151
- Dates
-
Created 2026-03-14Updated 2026-04-06Summarized 2026-04-05
Query time: 696 ms